PPP6R1 (SAPS1) is a conserved regulatory subunit of the PP6 serine/threonine phosphatase holoenzyme that, in partnership with the catalytic subunit PPP6C, directs substrate-specific dephosphorylation across cell division, DNA repair, and immune signaling (PMID:20040490, PMID:31751917). In dividing cells, the PP6 (PPH-6/SAPS-1) complex governs spindle positioning by controlling cortical actomyosin contractility and by negatively regulating Aurora A kinase localization at the cell cortex, with downstream effects on cortical recruitment of NuMA and dynein (PMID:20040490, PMID:27335426). In the DNA damage response, PPP6R1 is the regulatory subunit that mediates recognition of DNA-PKcs and is required for timely dephosphorylation of γH2AX, p53, and Kap1 after ionizing radiation; its loss renders cells and mice radiosensitive (PMID:31751917). PPP6R1 also functions in immune and cell-death signaling: it exerts negative control over NF-κB signaling and, through interaction with Slfn2, dampens type I IFN-induced NF-κB activation and interferon-stimulated gene expression (PMID:28620030, PMID:29866656). Acting redundantly with PPP6R2 and PPP6R3, PPP6R1 tunes RIPK1-dependent PANoptosis by promoting pro-death RIPK1 S166 autophosphorylation while reducing pro-survival S321 phosphorylation (PMID:38807188). PP6 containing PPP6R1 additionally binds the PB1 and PB2 subunits of the influenza A virus RNA-dependent RNA polymerase and positively supports viral RdRP activity (PMID:25187537). PPP6R1 is expressed at especially high levels in hematopoietic and lymphoid tissues, where its loss disrupts lymphocyte development and signaling (PMID:28620030).